I think it’s probably not appropriate to mix the BARDA application.award with the 510k application. The 510k application relates to use of BTM in surgical wounds while the BARDA application relates to funding of trials for use in mass burns.
I’ve heard nothing to indicate any change to BARDA’s already announced timetable: "It is anticipated that 1-2 cost reimbursement/firm-fixed price contract awards may be awarded in September 2015. The anticipated period of performance for any resultant contracts will be for a total of 60 months."
Ann: App 4E / Full Year Statutory Accounts, page-5
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.42 |
Change
-0.050(2.02%) |
Mkt cap ! $1.670B | |||
| Open | High | Low | Value | Volume |
| $2.40 | $2.45 | $2.35 | $3.794M | 1.575M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2112 | $2.41 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.42 | 27096 | 4 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| PNV (ASX) Chart |